TY  - RPRT
TI  - Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent In Vitro Antiviral Activity Against SARS-CoV-2
AU  - Bakovic, A.
AU  - Risner, K.
AU  - Bhalla, N.
AU  - Alem, F.
AU  - Chang, T. L.
AU  - Weston, W.
AU  - Harness, J. A.
AU  - Narayanan, A.
PY  - 2020
DO  - 10.1101/2020.10.29.352450
UR  - https://www.biorxiv.org/content/10.1101/2020.10.29.352450v1
ID  - 10.1101/2020.10.29.352450
ER  -